SALT LAKE CITY--(BUSINESS WIRE)--April 18, 2006--Myriad Genetics, Inc. (Nasdaq:MYGN - News) has arranged a conference call with the management team to provide a company update. Peter Meldrum, President and Chief Executive Officer will host the call along with Jay Moyes, Chief Financial Officer, Gregory Critchfield, M.D., President of Myriad Genetic Laboratories, Inc., Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc., and Jerry Lanchbury, Ph.D., Executive Vice President of Research.
